# A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

> **NCT00505388** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5137 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00505388
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 5137 (ACTUAL)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505388, "A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00505388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*